Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGDR2 | Q9Y5Y4 | 4/20 | 0.33 |
| ▸ | PRCP | P42785 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | PTGDR | Q13258 | 1/20 | 0.31 |
| ▸ | FEN1 | P39748 | 2/20 | 0.31 |
| ▸ | ALOX5AP | P20292 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21451531 | 0.95 | PTGDR2 (0.34) | PTGDR2PRCPKDM4EPTGDRFEN1 | |
| SCHEMBL21451516 | 0.92 | PTGDR2 (0.34) | PTGDR2PRCPKDM4EPTGDR | |
| SCHEMBL12140874 | 0.89 | KDM4E (0.34) | KDM4E | |
| SCHEMBL30093781 | 0.89 | KDM4E (0.34) | KDM4E | |
| SCHEMBL19986385 | 0.88 | FEN1 (0.37) | PTGDR2PTGDRFEN1ALOX5AP | |
| SCHEMBL18517278 | 0.87 | HTR2C (0.38) | PTGDR2PRCPPTGDR | |
| SCHEMBL19985280 | 0.87 | — | — | |
| SCHEMBL4402626 | 0.85 | ALDH1A1 (0.31) | — | |
| SCHEMBL12733641 | 0.85 | KDM4E (0.36) | KDM4E | |
| SCHEMBL23968127 | 0.84 | KDM4E (0.36) | KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11522141-B2 | Electronic switching element | MERCK PATENT GMBH (DE) | 2022-12-06 | — | — | US | disclosed |
| US-20210292651-A1 | ELECTRONIC SWITCHING ELEMENT | MERCK PATENT GMBH (DE) | 2021-09-23 | — | — | US | disclosed |
| US-20180079959-A1 | LIQUID CRYSTAL ELEMENT WITH NEGATIVE DIELECTRIC ANISOTROPY | DIC CORPORATION (JP) | 2018-03-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11522141-B2 | Electronic switching element | DNMT3A, DNMT1, DNMT3B | PTGDR2 293/4885PRCP 4752/4885KDM4E 2993/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.